Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival
- Status
- UNKNOWN
- Phase
- N/A
Effect of Hemp-CBD on Patients With CIPN
- Status
- UNKNOWN
- Phase
- PHASE2
First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Niraparib in Patients With Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Apatinib and Etoposide Capsule Versus Apatinib in Patients With Platinum Resistant Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care
- Status
- WITHDRAWN
- Phase
- NA
Effect of PARP Inhibitors on Glomerular Filtration Rate
- Status
- TERMINATED
- Phase
- N/A
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE4
Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Effectiveness of Care in Certified Cancer Centres in Germany
- Status
- COMPLETED
- Phase
- N/A
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers
- Status
- COMPLETED
- Phase
- NA
Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Feasibility of Frailty Assessment and Implementation of Interventions in Women Over 70 With Epithelial Ovarian Cancer
- Status
- UNKNOWN
- Phase
- NA